1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Rapid Microbiology Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Rapid Microbiology Testing Market, by Product
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast
8.1.2. Reagents and Kits
8.1.2.1. Market Revenue and Forecast
8.1.3. Consumables
8.1.3.1. Market Revenue and Forecast
9.1. Rapid Microbiology Testing Market, by Method
9.1.1. Growth-Based Rapid Microbiology Testing
9.1.1.1. Market Revenue and Forecast
9.1.2. Cellular component-Based Rapid Microbiology Testing
9.1.2.1. Market Revenue and Forecast
9.1.3. Nucleic Acid-Based Rapid Microbiology Testing
9.1.3.1. Market Revenue and Forecast
9.1.4. Viability-Based Rapid Microbiology Testing
9.1.4.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product
10.1.2. Market Revenue and Forecast, by Method
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product
10.1.3.2. Market Revenue and Forecast, by Method
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product
10.1.4.2. Market Revenue and Forecast, by Method
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product
10.2.2. Market Revenue and Forecast, by Method
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product
10.2.3.2. Market Revenue and Forecast, by Method
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product
10.2.4.2. Market Revenue and Forecast, by Method
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product
10.2.5.2. Market Revenue and Forecast, by Method
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product
10.2.6.2. Market Revenue and Forecast, by Method
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product
10.3.2. Market Revenue and Forecast, by Method
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product
10.3.3.2. Market Revenue and Forecast, by Method
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product
10.3.4.2. Market Revenue and Forecast, by Method
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product
10.3.5.2. Market Revenue and Forecast, by Method
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product
10.3.6.2. Market Revenue and Forecast, by Method
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product
10.4.2. Market Revenue and Forecast, by Method
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product
10.4.3.2. Market Revenue and Forecast, by Method
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product
10.4.4.2. Market Revenue and Forecast, by Method
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product
10.4.5.2. Market Revenue and Forecast, by Method
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product
10.4.6.2. Market Revenue and Forecast, by Method
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product
10.5.2. Market Revenue and Forecast, by Method
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product
10.5.3.2. Market Revenue and Forecast, by Method
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product
10.5.4.2. Market Revenue and Forecast, by Method
11.1. Creative Diagnostics
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. bioMérieux
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Synbiosis
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Thermo Fisher Scientific
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. MERLIN
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Danaher Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Merck Group
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Zhuhai DL Biotech.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Hi-Media
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
